Figures below are as of 21 Jul 2026. GMP is an unofficial, unregulated indicator of grey-market demand and is not investment advice.
| Grey Market Premium (GMP) | ₹68 |
| Estimated listing gain | +52.7% |
| Estimated listing price | ₹197 |
| Issue price | ₹129 |
| Issue size | ₹24.77 Cr |
| Subscription | 1.83x |
| Open date | 28 Jan 2026 |
| Close date | 30 Jan 2026 |
| Listing date | 04 Feb 2026 |
| Listing at | BSE SME |
| IPO type | SME |
| Registrar | Kfin Technologies Ltd. |
As of 21 Jul 2026, the grey market premium (GMP) for the Accretion Nutraveda Ltd. IPO is ₹68, implying an estimated listing gain of about +52.7% and an estimated listing price near ₹197. GMP is unofficial and unregulated — it indicates grey-market sentiment, not a guaranteed listing price.
The Accretion Nutraveda Ltd. IPO is open for subscription from 28 Jan 2026 to 30 Jan 2026. It is expected to list on 04 Feb 2026.
The Accretion Nutraveda Ltd. IPO is priced at ₹129 per share, with a total issue size of ₹24.77 Cr.
As of 21 Jul 2026, the Accretion Nutraveda Ltd. IPO is subscribed 1.83x.